Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Modulation of endoplasmic reticulum stress and the unfolded protein response in cancerous and noncancerous cells.

Purnell MC, Butawan MB, Bingol K, Tolley EA, Whitt MA.

SAGE Open Med. 2018 Jun 20;6:2050312118783412. doi: 10.1177/2050312118783412. eCollection 2018.

2.

Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses.

Whitt MA, Geisbert TW, Mire CE.

Methods Mol Biol. 2016;1403:295-311. doi: 10.1007/978-1-4939-3387-7_16.

PMID:
27076138
3.

Rab43 regulates the sorting of a subset of membrane protein cargo through the medial Golgi.

Cox JV, Kansal R, Whitt MA.

Mol Biol Cell. 2016 Jun 1;27(11):1834-44. doi: 10.1091/mbc.E15-03-0123. Epub 2016 Apr 6.

4.

Inhibition of melanocortin 1 receptor slows melanoma growth, reduces tumor heterogeneity and increases survival.

Kansal RG, McCravy MS, Basham JH, Earl JA, McMurray SL, Starner CJ, Whitt MA, Albritton LM.

Oncotarget. 2016 May 3;7(18):26331-45. doi: 10.18632/oncotarget.8372.

5.

Bioelectrodynamics: A New Patient Care Strategy for Nursing, Health, and Wellness.

Purnell MC, Whitt MA.

Holist Nurs Pract. 2016 Jan-Feb;30(1):4-9. doi: 10.1097/HNP.0000000000000129.

PMID:
26633720
6.

Kinetically distinct sorting pathways through the Golgi exhibit different requirements for Arf1.

Whitt MA, Cox ME, Kansal R, Cox JV.

Traffic. 2015 Mar;16(3):267-83. doi: 10.1111/tra.12248. Epub 2015 Jan 12.

7.

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.

Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW.

Virol J. 2013 Dec 13;10:353. doi: 10.1186/1743-422X-10-353.

8.

Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1.

Du Z, Whitt MA, Baumann J, Garner JM, Morton CL, Davidoff AM, Pfeffer LM.

J Interferon Cytokine Res. 2012 Aug;32(8):368-77. doi: 10.1089/jir.2012.0002. Epub 2012 Apr 17. Erratum in: J Interferon Cytokine Res. 2016 Aug;36(8):525.

9.

Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment.

Talekar A, Pessi A, Glickman F, Sengupta U, Briese T, Whitt MA, Mathieu C, Horvat B, Moscona A, Porotto M.

PLoS One. 2012;7(3):e30538. doi: 10.1371/journal.pone.0030538. Epub 2012 Mar 2.

10.

Use of replication restricted recombinant vesicular stomatitis virus vectors for detection of antigen-specific T cells.

Moseley NB, Laur O, Ibegbu CC, Loria GD, Ikwuenzunma G, Jayakar HR, Whitt MA, Altman JD.

J Immunol Methods. 2012 Jan 31;375(1-2):118-28. doi: 10.1016/j.jim.2011.09.016. Epub 2011 Oct 8.

11.

Utilization of fluorescently-labeled tetracysteine-tagged proteins to study virus entry by live cell microscopy.

Whitt MA, Mire CE.

Methods. 2011 Oct;55(2):127-36. doi: 10.1016/j.ymeth.2011.09.002. Epub 2011 Sep 10.

PMID:
21939769
12.

The protease-sensitive loop of the vesicular stomatitis virus matrix protein is involved in virus assembly and protein translation.

Mire CE, Whitt MA.

Virology. 2011 Jul 20;416(1-2):16-25. doi: 10.1016/j.virol.2011.04.013. Epub 2011 May 18.

13.
14.

A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating.

Mire CE, White JM, Whitt MA.

PLoS Pathog. 2010 Jul 15;6(7):e1000994. doi: 10.1371/journal.ppat.1000994.

15.

Binding and activation of host plasminogen on the surface of Francisella tularensis.

Clinton SR, Bina JE, Hatch TP, Whitt MA, Miller MA.

BMC Microbiol. 2010 Mar 12;10:76. doi: 10.1186/1471-2180-10-76.

16.

Enhanced oncolytic activity of vesicular stomatitis virus encoding SV5-F protein against prostate cancer.

Chang G, Xu S, Watanabe M, Jayakar HR, Whitt MA, Gingrich JR.

J Urol. 2010 Apr;183(4):1611-8. doi: 10.1016/j.juro.2009.12.005. Epub 2010 Feb 20.

PMID:
20172545
17.

Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein.

Mire CE, Dube D, Delos SE, White JM, Whitt MA.

J Virol. 2009 Dec;83(23):12139-50. doi: 10.1128/JVI.00955-09. Epub 2009 Sep 23.

18.

Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity.

Lavine CL, Clinton SR, Angelova-Fischer I, Marion TN, Bina XR, Bina JE, Whitt MA, Miller MA.

Eur J Immunol. 2007 Nov;37(11):3007-20.

19.

A novel role for a YXXPhi motif in directing the caveolin-dependent sorting of membrane-spanning proteins.

Dorsey FC, Muthusamy T, Whitt MA, Cox JV.

J Cell Sci. 2007 Aug 1;120(Pt 15):2544-54. Epub 2007 Jul 10.

20.

Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins.

Tani H, Komoda Y, Matsuo E, Suzuki K, Hamamoto I, Yamashita T, Moriishi K, Fujiyama K, Kanto T, Hayashi N, Owsianka A, Patel AH, Whitt MA, Matsuura Y.

J Virol. 2007 Aug;81(16):8601-12. Epub 2007 Jun 6.

21.

Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus.

Perez M, Clemente R, Robison CS, Jeetendra E, Jayakar HR, Whitt MA, de la Torre JC.

J Virol. 2007 Jun;81(11):5527-36. Epub 2007 Mar 21.

22.

IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors.

Klas SD, Lavine CL, Whitt MA, Miller MA.

Vaccine. 2006 Feb 27;24(9):1451-61. Epub 2005 Sep 23.

PMID:
16310294
23.

RNA interference is an antiviral defence mechanism in Caenorhabditis elegans.

Wilkins C, Dishongh R, Moore SC, Whitt MA, Chow M, Machaca K.

Nature. 2005 Aug 18;436(7053):1044-7.

PMID:
16107852
24.

Rhabdovirus assembly and budding.

Jayakar HR, Jeetendra E, Whitt MA.

Virus Res. 2004 Dec;106(2):117-32. Review.

PMID:
15567492
25.

Kinetics of protective antibodies are determined by the viral surface antigen.

Pinschewer DD, Perez M, Jeetendra E, Bächi T, Horvath E, Hengartner H, Whitt MA, de la Torre JC, Zinkernagel RM.

J Clin Invest. 2004 Oct;114(7):988-93.

26.
27.

Recombinant vesicular stomatitis virus vectors as oncolytic agents in the treatment of high-grade gliomas in an organotypic brain tissue slice-glioma coculture model.

Duntsch CD, Zhou Q, Jayakar HR, Weimar JD, Robertson JH, Pfeffer LM, Wang L, Xiang Z, Whitt MA.

J Neurosurg. 2004 Jun;100(6):1049-59.

PMID:
15200120
28.

Role of the cyclic AMP-dependent protein kinase in homologous resensitization of the beta1-adrenergic receptor.

Gardner LA, Delos Santos NM, Matta SG, Whitt MA, Bahouth SW.

J Biol Chem. 2004 May 14;279(20):21135-43. Epub 2004 Feb 27. Erratum in: J Biol Chem. 2007 Jun 29;282(26):19272.

29.

Recombinant replication-restricted VSV as an expression vector for murine cytokines.

Miller MA, Lavine CL, Klas SD, Pfeffer LM, Whitt MA.

Protein Expr Purif. 2004 Jan;33(1):92-103.

PMID:
14680966
30.
31.

Adjuvanticity of an IL-12 fusion protein expressed by recombinant deltaG-vesicular stomatitis virus.

Klas SD, Robison CS, Whitt MA, Miller MA.

Cell Immunol. 2002 Jul-Aug;218(1-2):59-73.

PMID:
12470614
32.
33.

A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?

Neumann G, Whitt MA, Kawaoka Y.

J Gen Virol. 2002 Nov;83(Pt 11):2635-2662. doi: 10.1099/0022-1317-83-11-2635. Review.

PMID:
12388800
35.

Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction.

Harty RN, Brown ME, McGettigan JP, Wang G, Jayakar HR, Huibregtse JM, Whitt MA, Schnell MJ.

J Virol. 2001 Nov;75(22):10623-9.

36.

Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor.

He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, Baker TS, Kuhn RJ, Anderson CW, Freimuth P, Rossmann MG.

Nat Struct Biol. 2001 Oct;8(10):874-8.

37.

Characterization of pseudotype VSV possessing HCV envelope proteins.

Matsuura Y, Tani H, Suzuki K, Kimura-Someya T, Suzuki R, Aizaki H, Ishii K, Moriishi K, Robison CS, Whitt MA, Miyamura T.

Virology. 2001 Aug 1;286(2):263-75.

38.
41.

Mutational analysis of the putative fusion domain of Ebola virus glycoprotein.

Ito H, Watanabe S, Sanchez A, Whitt MA, Kawaoka Y.

J Virol. 1999 Oct;73(10):8907-12.

45.

A system for functional analysis of Ebola virus glycoprotein.

Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y.

Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14764-9.

47.
49.

Normal replication of vesicular stomatitis virus without C proteins.

Kretzschmar E, Peluso R, Schnell MJ, Whitt MA, Rose JK.

Virology. 1996 Feb 15;216(2):309-16.

50.

Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.

Yang Y, Vanin EF, Whitt MA, Fornerod M, Zwart R, Schneiderman RD, Grosveld G, Nienhuis AW.

Hum Gene Ther. 1995 Sep;6(9):1203-13.

PMID:
8527479

Supplemental Content

Loading ...
Support Center